http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3301448-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_daf65ba00eabf4791bfdbd42b82911bd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2013-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c88094049b0bc65238ffdc401e0b13b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b73066f2ec04f593d6c303e842b3441 |
| publicationDate | 2018-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3301448-A1 |
| titleOfInvention | Methylglyoxal as a marker of cancer |
| abstract | The invention relates to a reliable, sensitive and easy to handle diagnostic and prognostic test of cancer, by measuring and analyzing the production of methylglyoxal (MG) from metabolically active cancer cells; in biological samples of extracellular fluids, cells and/or tissues of human or animal subjects. It uses any chemical or immunological in vitro method for MG measurement and it provides a kit for the early detection, screening and diagnosis of cancer; for the staging of cancer, for predicting the survival odds of cancer patients, for monitoring therapeutic response to anticancer programs (including prevention and prophylactic treatments), and for prediction and early detection of cachexia. |
| priorityDate | 2012-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.